Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25(OH)D concentrations in healthy women

Journal of Inflammation

Volumn 5, Issue , 2008, Pages

  Peterson, Catherine A ^a   Heffernan, Mary E ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; ESTRADIOL; HYDROCORTISONE; INTERLEUKIN 6; PARATHYROID HORMONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; ARTICLE; BLOOD SAMPLING; BODY COMPOSITION; BODY FAT; BODY MASS; CONTROLLED STUDY; DIETARY INTAKE; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTRADIOL BLOOD LEVEL; FEMALE; HEALTH STATUS; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; LINEAR REGRESSION ANALYSIS; MENOPAUSE; NORMAL HUMAN; OBSERVATIONAL STUDY; PARATHYROID HORMONE BLOOD LEVEL; PROTEIN BLOOD LEVEL; RADIATION EXPOSURE; SUN EXPOSURE; ULTRAVIOLET B RADIATION; VITAMIN BLOOD LEVEL;

EID: 49249085519     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-5-10     Document Type: Article

References (78)

1. Comparisons of estimated economic burdens due to insufficient solar ultraviolet irradiance and vitamin D and excess solar UV irradiance for the United States. WB Grant CF Garland MF Holick, Photochem Photobiol 2005 81 1276 1286 10.1562/2005-01-24-RA-424 16159309
2. The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. WB Grant CF Garland, Anticancer Res 2006 26 2687 2699 16886679
3. Ultraviolet B radiation improves serum levels of vitamin D in patients with cystic fibrosis. E Gronowitz O Larko M Gilljam A Hollsing A Lindblad D Mellstrom B Strandvik, Acta Paediatr 2005 94 547 552 10.1080/08035250410025276 16188742
4. Treatment of vitamin D deficiency due to Crohn's disease with tanning bed ultraviolet B radiation. P Koutkia Z Lu TC Chen MF Holick, Gastroenterology 2001 121 1485 1488 10.1053/gast.2001.29686 11729127
5. UVR, vitamin D and three autoimmune diseases - multiple sclerosis, type 1 diabetes, rheumatoid arthritis. AL Ponsonby RM Lucas IA vanderMei, Photochem Photobiol 2005 81 1267 1275 10.1562/2005-02-15-IR-441 15971932
6. Tanning is associated with optimal vitamin D status (serum 25-hydroxyvitamin D concentration) and higher bone mineral density. V Tangpricha A Turner C Spina S Decastro TC Chen MF Holick, Am J Clin Nutr 2004 80 1645 1649 15585781
7. The role of vitamin D for bone health and fracture prevention. MF Holick, Curr Osteoporos Rep 2006 4 96 102 10.1007/BF02686953 16907998
8. The Vitamin D requirement in health and disease. RP Heaney, J Steroid Biochem Mol Biol 2005 97 13 19 10.1016/j.jsbmb.2005.06.020 16026981
9. High prevalence of vitamin D inadequacy and implications for health. MF Holick, Mayo Clin Proc 2006 81 353 373 16529140
10. Resurrection of vitamin D deficiency and rickets. MF Holick, J Clin Invest 2006 116 2062 2072 16886050 10.1172/JCI29449
11. Prevalence of vitamin D insufficiency in an adult normal population. MC Chapuy P Preziosi M Maamer S Arnaud P Galan S Hercberg PJ Meunier, Osteoporos Int 1997 7 439 443 10.1007/s001980050030 9425501
12. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. SS Schleithoff A Zittermann G Tenderich HK Berthold P Stehle R Koerfer, Am J Clin Nutr 2006 83 754 759 16600924
13. Vitamin D: its role in cancer prevention and treatment. MF Holick, Prog Biophys Mol Biol 2006 92 49 59 10.1016/j.pbiomolbio.2006.02.014 16566961
14. Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? MT Cantorna, Proc Soc Exp Biol Med 2000 223 230 233 10.1046/j.1525-1373.2000.22333.x 10719834
15. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. MT Cantorna Y Zhu M Froicu A Wittke, Am J Clin Nutr 2004 80 1717S 1720S 15585793
16. Vitamin D: its role and uses in immunology. HF Deluca MT Cantorna, FASEB J 2001 15 2579 2585 10.1096/fj.01-0433rev 11726533
17. The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. C Mathieu L Adorini, Trends Mol Med 2002 8 174 179 10.1016/S1471-4914(02)02294-3 11927275
18. Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. L Overbergh B Decallonne D Valckx A Verstuyf J Depovere J Laureys O Rutgeerts R Saint-Arnaud R Bouillon C Mathieu, Clin Exp Immunol 2000 120 139 146 10759775 10.1046/j.1365-2249.2000.01204.x
19. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. E vanEtten C Mathieu, J Steroid Biochem Mol Biol 2005 97 93 101 10.1016/j.jsbmb.2005.06.002 16046118
20. Vitamin D in rheumatoid arthritis. M Cutolo K Otsa M Uprus S Paolino B Seriolo, Autoimmun Rev 2007 7 59 64 10.1016/j.autrev.2007.07.001 17967727
21. UV radiation, vitamin D and human health: an unfolding controversy introduction. AR Young SL Walker, Photochem Photobiol 2005 81 1243 1245 10.1562/2005-10-16-RA-716 16354109
22. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. K Sadeghi B Wessner U Laggner M Ploder D Tamandl J Friedl U Zugel A Steinmeyer A Pollak E Roth G Boltz-Nitulescu A Spittler, Eur J Immunol 2006 36 361 370 10.1002/eji.200425995 16402404
23. Re: epidemic influenza and vitamin D. JF Aloia M Li-Ng, Epidemiol Infect 2007 135 1095 1096 10.1017/S0950268807008308 17352842
24. Fighting infections with vitamin D. M Zasloff, Nat Med 2006 12 388 390 10.1038/nm0406-388 16598282
25. Hypothesis - ultraviolet-B irradiance and vitamin D reduce the risk of viral infections and thus their sequelae, including autoimmune diseases and some cancers. WB Grant, Photochem Photobiol 2008 84 356 365 10.1111/j.1751-1097. 2007.00266.x 18179620
26. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. PT Liu S Stenger H Li L Wenzel BH Tan SR Krutzik MT Ochoa J Schauber K Wu C Meinken DL Kamen M Wagner R Bals A Steinmeyer U Zugel RL Gallo D Eisenberg M Hewison BW Hollis JS Adams BR Bloom RL Modlin, Science 2006 311 1770 1773 10.1126/science.1123933 16497887
27. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. PT Liu S Stenger DH Tang RL Modlin, J Immunol 2007 179 2060 2063 17675463
28. SOLAR ultraviolet radiation and vitamin D: a historical perspective. K Rajakumar SL Greenspan SB Thomas MF Holick, Am J Public Health 2007 97 1746 1754 10.2105/AJPH.2006.091736 17761571
29. Calculated ultraviolet exposure levels for a healthy vitamin D status. AR Webb O Engelsen, Photochem Photobiol 2006 82 1697 1703 16958558
30. The validity and practicality of sun-reactive skin types I through VI. TB Fitzpatrick, Arch Dermatol 1988 124 869 871 10.1001/archderm.124.6.869 3377516
31. Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. S Salvini DJ Hunter L Sampson MJ Stampfer GA Colditz B Rosner WC Willett, Int J Epidemiol 1989 18 858 867 10.1093/ije/18.4.858 2621022
32. Serum markers of inflammation and endothelial function are elevated by hormonal contraceptive use but not exercise-associated menstrual disorders in physically active young women. PS Hinton Rector.R.S. JE Peppers RD Imhoff LS Hillman, J Sports Sci Med 2006 5 235 242
33. Measurement of cytokines in clinical samples using immunoassays: problems and pitfalls. RE Banks, Crit Rev Clin Lab Sci 2000 37 131 182 10.1080/10408360091174187 10811142
34. The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. C Popa MG Netea PL van Riel JW van der Meer AF Stalenhoef, J Lipid Res 2007 48 751 762 10.1194/jlr.R600021-JLR200 17202130
35. D-hormone and the immune system. MT Cantorna BD Mahon, J Rheumatol Suppl 2005 76 11 20 16142846
36. 1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. MT Cantorna WD Woodward CE Hayes HF Deluca, J Immunol 1998 160 5314 5319 9605130
37. Regulation of TNF-alpha by 1alpha,25-dihydroxyvitamin D3 in human macrophages from CAPD patients. ML Cohen A Douvdevani C Chaimovitz S Shany, Kidney Int 2001 59 69 75 10.1046/j.1523-1755.2001.00467.x 11135059
38. Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells. KN Evans L Nguyen J Chan BA Innes JN Bulmer MD Kilby M Hewison, Biol Reprod 2006 75 816 822 10.1095/biolreprod.106.054056 16957024
39. Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Y Zhu BD Mahon M Froicu MT Cantorna, Eur J Immunol 2005 35 217 224 10.1002/eji.200425491 15593122
40. The effects of calcitriol therapy on serum interleukin-1, interleukin-6 and tumour necrosis factor-alpha concentrations in post-menopausal patients with osteoporosis. A Inanir K Ozoran H Tutkak B Mermerci, J Int Med Res 2004 32 570 582 15587751
41. Comparative efficacy of oral and intravenous calcitriol treatment in haemodialysis patients: effects on serum biochemistry and cytokine levels. A Borazan H Ustun A Cefle N Sekitmez A Yilmaz, J Int Med Res 2003 31 489 496 14708413
42. Immunological surrogate markers of disease activity in multiple sclerosis. BC Kieseier G Giovannoni HP Hartung, Electroencephalogr Clin Neurophysiol Suppl 1999 50 570 583 10689511
43. Biomarkers for diagnosing and monitoring autoimmune diseases. HE Prince, Biomarkers 2005 10 Suppl 1 S44 S49 10.1080/13547500500214194 16298911
44. Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosis. G Giovannoni DH Miller NA Losseff M Sailer N Lewellyn-Smith AJ Thompson EJ Thompson, J Neurol 2001 248 487 495 10.1007/s004150170158 11499639
45. Tumor necrosis factor-alpha in serum of patients with inflammatory bowel disease as measured by a highly sensitive immuno-PCR. M Komatsu D Kobayashi K Saito D Furuya A Yagihashi H Araake N Tsuji S Sakamaki Y Niitsu N Watanabe, Clin Chem 2001 47 1297 1301 11427462
46. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables. J Koller-Strametz R Pacher B Frey T Kos W Woloszczuk B Stanek, J Heart Lung Transplant 1998 17 356 362 9588580
47. Cytokine-based therapies in inflammatory bowel disease. LY Kam SR Targan, Curr Opin Gastroenterol 1999 15 302 307 10.1097/00001574-199907000-00005 17023962
48. High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease. J Martinez-Borra C Lopez-Larrea S Gonzalez D Fuentes A Dieguez EM Deschamps JM Perez-Pariente A Lopez-Vazquez FR de L Rodrigo, Am J Gastroenterol 2002 97 2350 2356 12358255
49. Serum C-reactive protein as a marker for wellness assessment. PC Kao SC Shiesh TJ Wu, Ann Clin Lab Sci 2006 36 163 169 16682512
50. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. G Targher L Bertolini R Padovani L Zenari L Scala M Cigolini G Arcaro, Clin Endocrinol (Oxf) 2006 65 593 597 10.1111/j.1365-2265.2006.02633.x 17054459
51. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. S Patel T Farragher J Berry D Bunn A Silman D Symmons, Arthritis Rheum 2007 56 2143 2149 10.1002/art.22722 17599737
52. Relationship between soluble markers of immune activation and bone turnover in post-menopausal women with rheumatoid arthritis. P Oelzner S Franke A Muller G Hein G Stein, Rheumatology (Oxford) 1999 38 841 847 10.1093/rheumatology/38.9.841 10515645
53. Bone turnover in prolonged critical illness: effect of vitamin D. G Vanden Berghe D VanRoosbroeck P Vanhove PJ Wouters L DePourcq R Bouillon, J Clin Endocrinol Metab 2003 88 4623 4632 10.1210/jc.2003-030358 14557432
54. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? PM Timms N Mannan GA Hitman K Noonan PG Mills Syndercombe-Court E Aganna CP Price BJ Boucher, QJM 2002 95 787 796 10.1093/qjmed/95.12.787 12454321
55. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. AG Pittas SS Harris PC Stark B Dawson-Hughes, Diabetes Care 2007 30 980 986 10.2337/dc06-1994 17277040
56. The role of monocytes and T cells in 1,25-dihydroxyvitamin D3 mediated inhibition of B cell function in vitro. K Muller C Heilmann LK Poulsen T Barington K Bendtzen, Immunopharmacology 1991 21 121 128 10.1016/0162-3109(91) 90015-Q 1880018
57. 1,25-Dihydroxyvitamin D inhibits lipopolysaccharide-induced immune activation in human endothelial cells. O Equils Y Naiki AM Shapiro K Michelsen D Lu J Adams S Jordan, Clin Exp Immunol 2006 143 58 64 16367934 10.1111/j.1365-2249.2005.02961.x
58. The action of a novel vitamin D3 analogue, OCT, on immunomodulatory function of keratinocytes and lymphocytes. M Komine Y Watabe S Shimaoka F Sato K Kake H Nishina M Ohtsuki H Nakagawa K Tamaki, Arch Dermatol Res 1999 291 500 506 10.1007/s004030050444 10541880
59. Beneficial effect of 1,25 dihydroxyvitamin D3 on cytokine-treated human pancreatic islets. R Riachy B Vandewalle S Belaich J Kerr-Conte V Gmyr F Zerimech M d'Herbomez J Lefebvre F Pattou, J Endocrinol 2001 169 161 168 10.1677/joe.0.1690161 11250657
60. Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women. MH Gannage-Yared M Azoury I Mansour R Baddoura G Halaby R Naaman, J Endocrinol Invest 2003 26 748 753 14669830
61. Endocrine and inflammatory markers as predictors of frailty. MT Puts M Visser JW Twisk DJ Deeg P Lips, Clin Endocrinol (Oxf) 2005 63 403 411 10.1111/j.1365-2265.2005.02355.x 16181232
62. Comparative effect of oral pulse and intravenous calcitriol treatment in hemodialysis patients: the effect on serum IL-1 and IL-6 levels and bone mineral density. S Turk M Akbulut A Yildiz M Gurbilek S Gonen Z Tombul M Yeksan, Nephron 2002 90 188 194 10.1159/000049041 11818704
63. Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption. EM Greenfield SM Shaw SA Gornik MA Banks, J Clin Invest 1995 96 1238 1244 7657797 10.1172/JCI118157
64. Effect of parathyroid hormone on release of interleukin 1 and interleukin 6 from cultured mouse osteoblastic cells. NH Li Y Ouchi Y Okamoto A Masuyama M Kaneki A Futami T Hosoi T Nakamura H Orimo, Biochem Biophys Res Commun 1991 179 236 242 10.1016/0006-291X(91)91360-O 1883354
65. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. WB Ershler ET Keller, Annu Rev Med 2000 51 245 270 10.1146/annurev.med.51.1.245 10774463
66. Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. AR Cappola QL Xue L Ferrucci JM Guralnik S Volpato LP Fried, J Clin Endocrinol Metab 2003 88 2019 2025 10.1210/jc.2002-021694 12727948
67. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. HJ Cohen CF Pieper T Harris KM Rao MS Currie, J Gerontol A Biol Sci Med Sci 1997 52 M201 M208 9224431
68. Serum IL-6 level and the development of disability in older persons. L Ferrucci TB Harris JM Guralnik RP Tracy MC Corti HJ Cohen B Penninx M Pahor R Wallace RJ Havlik, J Am Geriatr Soc 1999 47 639 646 10366160
69. Vitamin D insufficiency in North America. DA Hanley KS Davison, J Nutr 2005 135 332 337 15671237
70. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. E Hypponen C Power, Am J Clin Nutr 2007 85 860 868 17344510
71. Serum 25-hydroxyvitamin D concentrations of New Zealanders aged 15 years and older. JE Rockell CM Skeaff SM Williams TJ Green, Osteoporos Int 2006 17 1382 1389 10.1007/s00198-006-0118-x 16832715
72. Serum 25-hydroxyvitamin D concentrations in girls aged 4-8 y living in the southeastern United States. EM Stein EM Laing DB Hall DB Hausman MG Kimlin MA Johnson CM Modlesky AR Wilson RD Lewis, Am J Clin Nutr 2006 83 75 81 16400053
73. Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it. R Vieth DE Cole GA Hawker HM Trang LA Rubin, Eur J Clin Nutr 2001 55 1091 1097 10.1038/sj.ejcn.1601275 11781676
74. Low serum concentrations of 25-hydroxyvitamin D in older persons and the risk of nursing home admission. M Visser DJ Deeg MT Puts JC Seidell P Lips, Am J Clin Nutr 2006 84 616 622 16960177
75. The prevalence of hypovitaminosis D among US adults: data from the NHANES III. A Zadshir N Tareen D Pan K Norris D Martins, Ethn Dis 2005 15 4 Suppl 5 S5-97 101 16315387
76. The urgent need to recommend an intake of vitamin D that is effective. R Vieth H Bischoff-Ferrari BJ Boucher B Dawson-Hughes CF Garland RP Heaney MF Holick BW Hollis C Lamberg-Allardt JJ McGrath AW Norman R Scragg SJ Whiting WC Willett A Zittermann, Am J Clin Nutr 2007 85 649 650 17344484
77. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. HA Bischoff-Ferrari E Giovannucci WC Willett T Dietrich B Dawson-Hughes, Am J Clin Nutr 2006 84 18 28 16825677
78. Frequent tanning bed use, weight concerns, and other health risk behaviors in adolescent females (United States). DL O'Riordan AE Field AC Geller DR Brooks G Aweh GA Colditz AL Frazier, Cancer Causes Control 2006 17 679 686 10.1007/s10552-005-0453-9 16633915